Chris Wood, CEO of Reveal Dx
With lung cancer being the leading cause of cancer-related deaths worldwide, advancements in AI-powered healthcare technology are offering newfound hope. Over the span of the next few decades, AI…
Continue Reading
Harmonized ONcologY Biomedical Embedding Encoder (HONeYBEE) is an open-source framework that integrates multimodal biomedical data for oncology applications. It processes clinical data (structured and unstructured), whole-slide images, radiology scans, and molecular profiles to generate…
Continue Reading
Background: Cancer-related fatigue is a common and significant symptom experienced by cancer patients and survivors across all age groups, profoundly impacting their quality of life. Adolescents and young adults often encounter substantial academic, career,…
Continue Reading
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Wessam Sonbol, Founder and CEO at Delve Health. Sonbol founded Delve Health…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Wessam Sonbol, Founder and CEO at Delve Health. Sonbol founded Delve Health…
Continue Reading
Accurate ovarian cancer screening and diagnosis are critical for patient survival. We present UMORSS, an AI-assisted diagnostic system integrating ultrasound (US) imaging and clinical data with uncertainty quantification for precise ovarian cancer risk assessment….
Continue Reading
What You Should Know:
– Sutter Health, a large integrated, not-for-profit health system in California, is pioneering a game-changing initiative that brings advanced artificial intelligence (AI) to mammograms.
– In collaboration with AI governance partner Ferrum…
Continue Reading
Lawrence Tallon, chief executive at the Medicines and Healthcare products Regulatory Agency (Credit: MHRA)
AI tools that could improve patient care are being tested in the next phase of the Medicines and Healthcare products…
Continue Reading
Efficient and accurate identification of genetic alterations of non-small cell lung cancer is a critical diagnostic process for targeted therapies. Utilizing advanced modern deep learning is a potential solution that can accurately predict genetic…
Continue Reading
This study evaluates the CT-based volumetric sarcopenia index (SI) as a baseline prognostic factor for overall survival (OS) in 10,340 solid tumor patients (40% female). Automated body composition analysis was applied to internal baseline…
Continue Reading
